Tokyo Sangyo Co., Ltd. (TYO:8070)
Japan flag Japan · Delayed Price · Currency is JPY
925.00
-7.00 (-0.75%)
Aug 14, 2025, 9:44 AM JST

Oncternal Therapeutics Ratios and Metrics

Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 20212016 - 2020
Period Ending
Aug '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21 2016 - 2020
24,29318,03418,54218,80018,77017,629
Upgrade
Market Cap Growth
-2.74%-2.74%-1.37%0.16%6.47%34.77%
Upgrade
Enterprise Value
21,88515,85828,36226,11923,82022,255
Upgrade
Last Close Price
932.00692.00679.40668.88631.92544.39
Upgrade
PE Ratio
11.228.33--16.399.62
Upgrade
PS Ratio
0.340.260.280.290.340.16
Upgrade
PB Ratio
1.160.860.930.890.700.65
Upgrade
P/TBV Ratio
1.160.860.940.890.700.65
Upgrade
P/FCF Ratio
6.154.56----
Upgrade
P/OCF Ratio
4.543.371545.16---
Upgrade
EV/Sales Ratio
0.310.220.440.400.430.20
Upgrade
EV/EBITDA Ratio
7.615.43-16.838.109.10
Upgrade
EV/EBIT Ratio
9.847.00-36.0310.4411.73
Upgrade
EV/FCF Ratio
5.544.01----
Upgrade
Debt / Equity Ratio
0.650.651.010.790.550.50
Upgrade
Debt / EBITDA Ratio
4.704.70-10.795.025.55
Upgrade
Debt / FCF Ratio
3.473.47----
Upgrade
Asset Turnover
0.860.860.830.780.671.53
Upgrade
Inventory Turnover
12.5012.507.518.547.0127.21
Upgrade
Quick Ratio
0.900.900.770.670.480.65
Upgrade
Current Ratio
1.121.121.071.211.131.19
Upgrade
Return on Equity (ROE)
10.59%10.59%-7.96%-20.67%4.26%7.15%
Upgrade
Return on Assets (ROA)
1.71%1.71%-1.89%0.54%1.71%1.61%
Upgrade
Return on Capital (ROIC)
3.79%3.79%-3.81%1.14%3.47%3.22%
Upgrade
Return on Capital Employed (ROCE)
7.90%7.90%-2.40%6.80%5.40%
Upgrade
Earnings Yield
8.91%12.00%-8.54%-26.38%6.10%10.40%
Upgrade
FCF Yield
16.27%21.92%-2.17%-9.67%-11.51%-37.18%
Upgrade
Dividend Yield
4.11%5.20%5.30%4.49%4.11%4.78%
Upgrade
Payout Ratio
43.99%43.99%--65.33%39.17%
Upgrade
Buyback Yield / Dilution
-0.27%-0.27%-0.18%2.76%1.42%-0.56%
Upgrade
Total Shareholder Return
3.85%4.93%5.12%7.24%5.54%4.22%
Upgrade
Updated Feb 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.